Preliminary effects of low-intensity focused ultrasound treatment program for cancer-related neuropathic pain. Academic Article uri icon

Overview

abstract

  • Aim: To evaluate the effectiveness of low-intensity focused ultrasound (LIFU) therapy in the management of cancer-related neuropathic pain (CNP). Methods: A retrospective review with 22 patients with CNP treated with LIFU therapy (frequency 3 Hz, 3 W/cm2, pulse mode duty cycle 50%) was conducted. Results: Out of the 22 patients, 15 had CNP secondary to chemotherapy-induced peripheral neuropathy. Compared with baseline, there was a significant reduction in numeric pain rating scale (p < 0.001). Additionally, 76.5% of patients (n = 13) were considered to be responders to LIFU therapy. Conclusion: LIFU therapy may be a viable treatment modality in the management of CNP, specifically chemotherapy-induced peripheral neuropathy, with a minimal side effect profile. Larger, prospective studies with a structured protocol are necessary.

publication date

  • June 9, 2021

Research

keywords

  • Cancer Pain
  • Neoplasms
  • Neuralgia

Identity

Scopus Document Identifier

  • 85113143931

Digital Object Identifier (DOI)

  • 10.2217/pmt-2020-0099

PubMed ID

  • 34102872

Additional Document Info

volume

  • 11

issue

  • 5